| Sources | Names Used |
|---|---|
| CCLE, GDSC1000, FIMM | Nilotinib |
| CTRPv2 | nilotinib |
| PharmacoGx | Nilotinib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
| Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
| Pubchem: | 644241 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | APOL4 | CCLE | pan-cancer | AAC | 0.62 | 5e-41 |
| mRNA | CISH | CCLE | pan-cancer | AAC | 0.5 | 4e-23 |
| mRNA | CFAP161 | CCLE | pan-cancer | AAC | 0.42 | 1e-19 |
| mRNA | ANKRD55 | CCLE | pan-cancer | AAC | 0.41 | 8e-18 |
| mRNA | KLF1 | CCLE | pan-cancer | AAC | 0.36 | 7e-14 |
| mRNA | RREB1 | CCLE | pan-cancer | AAC | 0.39 | 8e-14 |
| mRNA | GFI1B | CCLE | pan-cancer | AAC | 0.35 | 9e-13 |
| mRNA | MLC1 | CCLE | pan-cancer | AAC | 0.37 | 2e-12 |
| mRNA | ATP7B | CCLE | pan-cancer | AAC | 0.33 | 1e-11 |
| mRNA | HPSE2 | CCLE | pan-cancer | AAC | 0.32 | 1e-11 |
